Cost-effectiveness of an inpatient nurse practitioner in heart failure

Eur J Cardiovasc Nurs. 2024 Jan 12;23(1):33-41. doi: 10.1093/eurjcn/zvad036.

Abstract

Aims: Heart failure (HF) nurse practitioners (NPs) are an important part of the HF specialist team, and their impact on the cost-effectiveness of their role is unknown. The aim of this study was to determine the cost-effectiveness of a HF NP inpatient service compared with current practice of no HF NP service from a health system perspective at 12 months and 3 years.

Methods and results: We developed a Markov model to estimate costs, effects, and cost-effectiveness for hospitalized HF patients and seen by a HF NP service compared with usual care at 12 months and 3 years. Costs and effects were taken from a retrospective observational cohort study. Transition probabilities and utilities were derived from published studies. A total of 500 patients were included (250 patients in the HF NP service vs. 250 patients in usual care). Average age was 77.7 ± 11 years, and 54% were male. At 12 months, the HF NP group was cheaper and more effective compared with no HF NP [$23 031 vs. $25 111 (AUD), respectively; quality-adjusted life years (QALYs) were 0.68 in HF NP group compared with 0.66 in usual care]. The incremental cost-effectiveness ratio showed a savings of $109 474 per QALY gained at 12 months and a savings of $270 667 per QALY gained at 3 years in favour of the HF NP service.

Conclusion: The HF NP service was cost-effective with lower costs and higher QALYs compared with no HF NP service. Economic evaluations alongside randomized controlled trials are warranted.

Keywords: Cost-effectiveness; Economic evaluation; Heart failure; Nurse practitioner.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cost-Benefit Analysis
  • Female
  • Heart Failure* / therapy
  • Humans
  • Inpatients*
  • Male
  • Retrospective Studies